{"id":"https://openalex.org/W2561840328","doi":"https://doi.org/10.1055/s-2006-933785","title":"Phase II-Studie zur Behandlung des vorbehandelten, fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC) mit Sorafenib (BAY 43\u20139006)","display_name":"Phase II-Studie zur Behandlung des vorbehandelten, fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC) mit Sorafenib (BAY 43\u20139006)","publication_year":2006,"publication_date":"2006-04-20","ids":{"openalex":"https://openalex.org/W2561840328","doi":"https://doi.org/10.1055/s-2006-933785","mag":"2561840328"},"language":"de","primary_location":{"id":"doi:10.1055/s-2006-933785","doi":"https://doi.org/10.1055/s-2006-933785","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2006-933785","pdf_url":null,"source":{"id":"https://openalex.org/S111957458","display_name":"Pneumologie","issn_l":"0934-8387","issn":["0934-8387","1438-8790"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pneumologie","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"A Lange","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140903","display_name":"LungenClinic Grosshansdorf","ror":"https://ror.org/041wfjw90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210140903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A Lange","raw_affiliation_strings":["KH Gro\u00dfhansdorf, Onkologischer Schwerpunkt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KH Gro\u00dfhansdorf, Onkologischer Schwerpunkt","institution_ids":["https://openalex.org/I4210140903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062933842","display_name":"Ulrich Gatzemeier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140903","display_name":"LungenClinic Grosshansdorf","ror":"https://ror.org/041wfjw90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210140903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"U Gatzemeier","raw_affiliation_strings":["KH Gro\u00dfhansdorf, Onkologischer Schwerpunkt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KH Gro\u00dfhansdorf, Onkologischer Schwerpunkt","institution_ids":["https://openalex.org/I4210140903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077579849","display_name":"George R. Blumenschein","orcid":"https://orcid.org/0000-0002-9606-8194","observed_orcids":["https://orcid.org/0000-0002-9606-8194"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G Blumenschein","raw_affiliation_strings":["M.D. Anderson Tumor Centre, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M.D. Anderson Tumor Centre, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052529897","display_name":"I. Bernard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"I Bernard","raw_affiliation_strings":["Bayer HealthCare AG, Leverkusen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare AG, Leverkusen","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113331833","display_name":"K. Burk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K Burk","raw_affiliation_strings":["Bayer HealthCare AG, Leverkusen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare AG, Leverkusen","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046728958","display_name":"Martin Reck","orcid":"https://orcid.org/0000-0002-5348-4462","observed_orcids":["https://orcid.org/0000-0002-5348-4462"]},"institutions":[{"id":"https://openalex.org/I4210140903","display_name":"LungenClinic Grosshansdorf","ror":"https://ror.org/041wfjw90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210140903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M Reck","raw_affiliation_strings":["KH Gro\u00dfhansdorf, Onkologischer Schwerpunkt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KH Gro\u00dfhansdorf, Onkologischer Schwerpunkt","institution_ids":["https://openalex.org/I4210140903"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.264,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.64708229,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"60","issue":"S 1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9269999861717224},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.8899999856948853},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.8569999933242798},{"id":"https://openalex.org/keywords/raf-kinase-inhibition","display_name":"Raf kinase inhibition","score":0.9160000085830688},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.8370000123977661},{"id":"https://openalex.org/keywords/pdgfrbeta","display_name":"PDGFR\u03b2","score":0.9380000233650208},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.7329999804496765},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.6029999852180481},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.5740000009536743},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9200000166893005},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.6940000057220459},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.671999990940094},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.9879999756813049},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.515999972820282},{"id":"https://openalex.org/keywords/recist-response-assessment","display_name":"RECIST response assessment","score":0.6240000128746033},{"id":"https://openalex.org/keywords/adenosquamous-carcinoma","display_name":"adenosquamous carcinoma","score":0.5379999876022339},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.9580000042915344}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7286894917488098},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.7244220972061157},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.708782970905304},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1702972948551178},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.10843732953071594}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1055/s-2006-933785","doi":"https://doi.org/10.1055/s-2006-933785","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2006-933785","pdf_url":null,"source":{"id":"https://openalex.org/S111957458","display_name":"Pneumologie","issn_l":"0934-8387","issn":["0934-8387","1438-8790"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pneumologie","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2249182920","https://openalex.org/W2469935629","https://openalex.org/W2337112079","https://openalex.org/W2127045236","https://openalex.org/W2589867092","https://openalex.org/W2562967539","https://openalex.org/W2011990380","https://openalex.org/W2517521286","https://openalex.org/W1969426527","https://openalex.org/W2998890386"],"abstract_inverted_index":{"Einf\u00fchrung:":[0],"Sorafenib,":[1],"ein":[2,90],"oraler":[3],"Multi-Kinase-Inhibitor,":[4],"hemmt":[5],"das":[6,165],"Tumorwachstum":[7],"durch":[8],"Inhibition":[9],"der":[10,13,82,138],"Raf-Kinase":[11],"und":[12,23,51,106,133,183,194,206],"Angiogenese":[14],"(VEGFR-2,":[15],"PDGFR-\u00df).":[16],"Nachdem":[17],"beim":[18,33,212],"Nierenzellkarzinom,":[19],"hepatozellul\u00e4ren":[20],"Karzinom,":[21],"Melanom":[22],"Sarkom":[24],"eine":[25,118,134],"Wirksamkeit":[26],"gezeigt":[27],"wurde,":[28],"pr\u00fcfte":[29],"diese":[30],"Studie":[31,211],"Sorafenib":[32,58,219],"vorbehandelten":[34,213],"NSCLC.":[35],"Methoden:":[36],"Es":[37],"wurden":[38],"54":[39],"Pat.":[40,56,83,198],"mit":[41,144,162,220],"NSCLC":[42,94,214],"im":[43],"Stadium":[44,91],"IV,":[45],"ECOG":[46,108],"0\u20132,":[47],"Progress":[48,64],"bei":[49,130,136,142,224],"Studienbeginn":[50],"1\u20132":[52],"Zytostatika-Vortherapien":[53],"eingeschlossen.":[54],"52":[55],"erhielten":[57],"400mg":[59],"2x":[60],"t\u00e4glich":[61],"bis":[62,66],"zum":[63,67],"bzw.":[65,153,157],"Auftreten":[68],"von":[69,103,110,218],"nicht":[70],"tolerablen":[71],"Toxizit\u00e4ten.":[72],"Prim\u00e4rer":[73],"Endpunkt":[74],"war":[75],"die":[76,115,200,216],"Ansprechrate":[77],"nach":[78],"RECIST.":[79],"Ergebnisse:":[80],"65%":[81],"waren":[84,175,191],"m\u00e4nnlich,":[85],"92%":[86],"Kaukasier,":[87],"94%":[88],"hatten":[89,114],"IV":[92],"des":[93],"(54%":[95],"Adeno-,":[96],"31%":[97,137],"Plattenepithelkarzinome).":[98],"Bei":[99,160],"einem":[100,107],"medianen":[101],"Alter":[102],"60,8":[104],"Jahren":[105],"Status":[109],"0:1:2":[111],"in":[112,124],"10%:85%:6%":[113],"Patienten":[116,139,161],"mindestens":[117],"systemische":[119],"Vortherapie":[120],"erhalten":[121],"(1:2:>2":[122],"Therapien":[123],"52%:44%:4%).":[125],"Stable":[126],"Disease":[127],"(SD)":[128],"wurde":[129],"62,5%":[131],"(n=30)":[132],"Tumorreduktion":[135],"nachgewiesen,":[140],"davon":[141],"8%":[143],"Reduktion":[145],"um":[146],"\u2265":[147,188],"30%.":[148],"Das":[149],"mediane":[150,166],"progressionsfreie":[151,167],"\u00dcberleben":[152,168],"Intervall":[154],"betrug":[155,164],"11,9":[156],"14,8":[158],"Wochen.":[159],"SD":[163],"166":[169],"Tage.":[170],"Die":[171],"h\u00e4ufigsten":[172],"medikamentenbezogenen":[173],"Nebenwirkungen":[174,187],"Diarrhoe":[176],"(40%),":[177],"Hand-Fu\u00df-Syndrom":[178],"(HFS)":[179],"(37%),":[180],"Fatigue":[181,192],"(27%)":[182],"Nausea":[184],"(25%).":[185],"H\u00e4ufige":[186],"Grad":[189],"3":[190,197],"(14%)":[193],"HFS":[195],"(10%).":[196],"brachen":[199],"Therapie":[201],"wegen":[202],"HFS,":[203],"erh\u00f6hter":[204],"Lipase":[205],"Myokardinfarkt":[207],"ab.":[208],"Folgerung:":[209],"Diese":[210],"belegt":[215],"Aktivit\u00e4t":[217],"viel":[221],"versprechenden":[222],"Langzeitverl\u00e4ufen":[223],"sehr":[225],"moderater":[226],"Toxizit\u00e4t.":[227],"Weitere":[228],"Studien":[229],"sind":[230],"geplant.":[231]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-01-06T00:00:00"}